Curaleaf International has acquired Polish medical cannabis operator Can4Med, giving the London-based company a foothold in one of Europe’s most promising medical marijuana markets. The financial terms of the deal were not disclosed.
Can4Med, based in Wroclaw, specializes in the acquisition, registration and distribution of medical cannabis, according to a Tuesday news release.
Curaleaf International, a subsidiary of New York-headquartered multistate operator Curaleaf Holdings, said the strategic acquisition underscores its commitment to growing patient access to medical cannabis products across Europe.